The global chip shortage comes as demand for cars has spiked during the global economy’s recovery from the coronavirus crisis, driving up prices of new and used vehicles.
Some carmakers have adapted to the chip shortage by dropping features from their models, while others have built vehicles without the necessary chips and then parked them until their assembly can be finished later.
The study also found that almost half of the Asian companies prefer dedicated seats for their staff, rather than sharing in what’s known as “hot-desking,” since most of them don’t intend to adopt hybrid work. While more than 60 per cent of the respondents said the staff-to-desk sharing ratio will increase over the coming couple of years, most of them were Western companies. That means an office desk will serve more employees in the future.
Businesses around the world, hamstrung by lockdowns, are facing often-existential showdowns with insurance companies that are reluctant to pay out on business interruption policy claims for a disaster unknown in living memory.
The insurers say many such policies exclude pandemics, require physical damage on premises or do not apply to the widespread lockdowns seen globally. Facing pressure from regulators, mounting reputational damage and a wave of lawsuits, they warn that paying out could sink their industry.
In some countries, including South Africa, France and Germany, insurers are now opening their chequebooks. But for many customers, these settlements or ex-gratia payments – voluntary payouts that do not imply legal liability – fall short.
The apex court said the National Disaster Management Plan prepared by the Centre deals with all aspects of the Biological and Public Health Emergencies in systematic and planned manner and thus there is no need of separate plan to deal with COVID-19 pandemic.
The bench said the National Disaster Management Authority was well aware of the epidemics and had issued guidelines in the year 2008 itself which has been further detailed in Plan-2019.
Implementation of testing aggressively, tracking comprehensively and treating efficiently through a plethora of measures have contributed to the existing high level of recoveries as well, it said. The total number of recoveries in the country rose to 18,62,258 on Sunday, according to official data.
Improved and effective clinical treatment in hospitals, supervised home isolation, use of non-invasive oxygen support, and improved services of the ambulances for ferrying patients for prompt and timely treatment have been the focus of the Centre and state and UT governments, the ministry said.
The European Commission, which is negotiating on behalf of all 27 EU member states, said the deal included an option to purchase 100 million additional doses from the British drugmaker should its vaccine prove safe and effective.
The EU’s bilateral deal mirrors moves by the United States and other wealthy states, some of which are critical of the WHO’s initiative, and further reduces the potentially available stock in the race to secure effective Covid-19 vaccines.
The EU move could complicate efforts led by the WHO and GAVI, a global alliance for vaccines, to buy shots on behalf of rich and developing countries with a separate scheme.
The Commission has urged EU states to shun the WHO-led initiative because it sees it as too expensive and slow, EU officials told Reuters in July
Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. CanSino has said it is also in talks with Russia, Brazil and Chile to launch Phase III trials in those countries.
Ravi Sharma, Retail Banking Analyst GlobalData’s, comments: “Contactless payments in Sweden is already growing at a faster pace, with Swedes increasingly making contactless payments in shops, restaurants and cafes. As a result of the pandemic, its usage is expected to become even more popular. The growing acceptance of contactless payments will support the adoption and use of NFC-enabled mobile wallet solutions, such as Apple Pay and Google Pay.”
“There can be a relapse. The virus can be isolated from the body particularly from the sputum. We have the evidence that after ninth or tenth day the virus becomes non-infectious and the patients are not tested again,” he said.
“However, the virus has been reported to be living in patients who have recovered around 39 to 40 days back,” he added.
Pandemic-related claims for vaccines will be routed to a rarely used USA federal program set up to encourage drugmakers to help combat public health emergencies. It spares pharmaceutical and device makers from costly liability lawsuits in exchange for taxpayers compensating injured patients — though it doesn’t guarantee there’s funding to do so.“We want people vaccinated and we don’t want to expose pharmaceutical companies to the kind of liability that they would otherwise have,” said Brent Johnson, a partner with Holland & Hart, who defends corporate clients. “That’s the price we’re willing to pay to get rid of this horrible coronavirus problem.”
Port Louis: Japanese bulk carrier that ran aground on a reef in Mauritius last month threatening a marine ecological disaster around the Indian Ocean island has broken apart, authorities said on Saturday. The condition of the MV Wakashio was worsening early on...
The strain could mean that existing studies on vaccines may be incomplete or ineffective against the mutation, said Director-General of Health Noor Hisham Abdullah.